Skip to content

The effects of HBOT on pain reduction after ARCR.

The effects of hyperbaric oxygen therapy on pain reduction after arthroscopic rotator cuff repair aiming to prevent complex regional pain syndrome.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs062240042
Enrollment
120
Registered
2024-08-01
Start date
2024-09-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff tear hyperbaric oxygen therapy, arthroscopic rotator cuff repair, complex regional pain syndrome

Interventions

hyperbaric oxygen therapy

Sponsors

Ishida Koji
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who aged between 50 and 85 years at the time of consent. 2. Patients who are scheduled for arthroscopic rotator cuff repair as part of routine clinical practice and are able to attend regular follow-up visits postoperatively. 3. Patients who are capable of effective communication (able to undergo physical examination, medical history taking, and scoring surveys).

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria will be excluded from this study: 1. Patients who have been diagnosed with CRPS (Complex Regional Pain Syndrome) before surgery. 2. Patients with a history of surgical treatment on the affected shoulder. 3. Patients with functional impairment of the affected upper limb due to diseases other than rotator cuff tears. 4. Patients unable to undergo MRI examinations due to implanted devices. 5. Women who are pregnant or may be pregnant. 6. Absolute contraindications for HBOT : Tension pneumothorax. 7. Relative contraindications for HBOT: (i) Spontaneous pneumothorax, bronchial asthma, chronic lung disease (such as emphysema), nasal polyps, upper respiratory inflammation, (ii) sinus constriction, (iii) history of tympanic membrane trauma, history of exudative otitis media, (iv) patients with difficulty in Eustachian tube opening, (v) postoperative retinal detachment, (vi) skull base fractures, pneumocephalus, brain tumors, (vii) seizure disorders, (viii) patients with a history of open chest surgery who may experience rapid ventilatory failure, (ix) potential for aspiration or choking, (x) serious arrhythmias or other significant respiratory and circulatory disorders, (xi) claustrophobia. 8. Other cases deemed inappropriate by the study investigator.

Design outcomes

Primary

MeasureTime frame
Change in shoulder pain visual analogue scale (VAS) scores up to two weeks postoperatively, using the second postoperative day as the baseline.

Secondary

MeasureTime frame
Change in shoulder pain visual analogue scale (VAS) scores at each evaluation time point (3 days, 1 week, 3 weeks, 4 weeks, 8 weeks, and 12 weeks postoperatively). Shoulder pain VAS scores and their progression at each evaluation time point (2 days, 3 days, 1 week, 2 weeks, 3 weeks, 4 weeks, 8 weeks, and 12 weeks postoperatively). Change and rate of change in physical examination findings at each evaluation time point (1 week, 2 weeks, 4 weeks, 8 weeks, and 12 weeks postoperatively), using the second postoperative day as the baseline: Maximum circumference of the forearm, maximum circumference of the upper arm, range of motion (elbow and wrist joints), grip strength. Change in the number of criteria met for the diagnosis of CRPS according to the Budapest criteria at each evaluation time point (1 week, 2 weeks, 4 weeks, 8 weeks, and 12 weeks postoperatively). Incidence and rate of occurrence of CRPS and CRPS-like symptoms at each evaluation time point (2 days, 1 week, 2 weeks, 4 weeks, 8 weeks, and 12 weeks postoperatively). Postoperative complications. Adverse events associated with HBOT.

Contacts

Public ContactKoji Ishida

Tottori University Hospital

k.ishida-ortho@tottori-u.ac.jp+81-859-38-6587

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026